The ADAP Advocacy Association (aaa+) mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. aaa+ works with advocates, community, health care, government, patients, pharmaceutical companies and other stakeholders to assure that access to services recognize and afford persons living with HIV/AIDS to enjoy a healthy life.

aaa+ is the only national grassroots organization focused exclusively on ADAPs and ensuring that there are adequate resources nationwide to eliminate or prevent waiting lists for services. Our purpose is to better engage people living with HIV/AIDS by providing a platform whereby they can offer their personal experiences, challenges, knowledge, insight and solutions to solving this perpetual problem.

Breaking News

ADAP Advocacy Association Elects Ramsell Holding Corporation’s President & CEO Eric Flowers on Board of Directors.

ADAPs with Waiting Lists
(4,611 individuals in 12 states*, as of January 19, 2012)

Alabama: 59 people
Florida: 1,109 people
Georgia: 1,348 people
Idaho: 5 people
Louisiana: 648 people**
Montana: 11 people
Nebraska: 18 people
North Carolina: 130 people
Ohio: 0 people
South Carolina: 174 people
Utah: 4 people***
Virginia: 1,105 people

ADAPs with Other Cost-Containment Strategies
(instituted since April 1, 2009, as of November 9, 2011)

Alabama: Reduced formulary
Arizona: Reduced formulary
Arkansas: Reduced formulary, lowered financial eligibility to 200% of FPL, (disenrolled 99 clients in September 2009)
Colorado: Reduced formulary
Florida: Reduced formulary, transitioned 5,403 clients to Welvista from 2/15-3/31/11
Georgia: Reduced formulary, implemented medical criteria, participating in the Alternative Method Demonstration Project (AMDP)
Illinois: Reduced formulary, lowered financial eligibility to 300% FPL (grandfathered in current enrollees from 301-500% FPL), instituted monthly expenditure cap ($2,000 per client per month), disenrolled clients not accessing ADAP for 90-days.
Kentucky: Reduced formulary
Louisiana: Discontinued reimbursement of laboratory assays
North Carolina: Reduced formulary
North Dakota: Capped enrollment, instituted annual expenditure cap, lowered financial eligibility to 300% FPL (grandfathered in current clients from 301-400% FPL)
Ohio: Reduced formulary, lowered financial eligibility to 300% of FPL (disenrolled 257 clients in July 2010)
Puerto Rico: Reduced formulary
South Carolina: Lowered financial eligibility to 300% FPL, (grandfathered in current clients from 301-550% FPL)
Utah: Reduced formulary, lowered financial eligibility to 250% of FPL (disenrolled 89 clients 9/09)
Virginia: Reduced formulary, restricted eligibility criteria, transitioned 204 clients onto waiting list
Washington: Instituted client cost sharing, reduced formulary, only paying insurance premium for clients currently on antiretrovirals
Wyoming: Capped enrollment, reduced formulary, instituted client cost sharing

ADAPs Considering New/Additional Cost-Containment Measures
(before March 31, 2012****)

Alaska: Reduce formulary
Florida: Lower financial eligibility
Kentucky: Reduce formulary
Montana: Reduce formulary
Oregon: Reduce formulary
Puerto Rico: Reduce formulary
Tennessee: Establish waiting list
Wyoming: Establish waiting list, lower financial eligibility, institute client cost sharing

*As a result of ADAP Emergency Funding, Hawaii, Idaho, Iowa, Kentucky, South Dakota, and Utah have eliminated their waiting lists. Idaho reinstituted a waiting list in February 2011.
**Louisiana has a capped enrollment on their program. This number is a representation of their current unmet need.
***Utah instituted a waiting list in May 2011. To date, no individuals have been added.
****March 31, 2011 is the end of ADAP FY2010. ADAP fiscal years begin April 1 and ends March 31.